The Toxoplasma gondii virulence factor ROP16 acts in cis and trans, and suppresses T cell responses

Longfei Chen1,2, David A Christian2, Joshua A Kochanowsky3

  • 1Department of Pathogen Biology, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.

Insights

Toxoplasma gondii

Area of Science:

  • Immunology
  • Molecular Biology
  • Parasitology

Background:

  • Toxoplasma gondii injects rhoptry kinase ROP16 into host cells, activating STAT3 and STAT6.
  • The precise impact of ROP16-mediated STAT activation on infection remains unclear.

Purpose of the Study:

  • To elucidate the role of ROP16 and STAT3/STAT6 in T. gondii infection.
  • To differentiate the effects of rhoptry protein injection from cellular infection.

Main Methods:

  • Utilized genetically modified parasites expressing Cre-recombinase with rhoptry proteins.
  • Employed transcriptional profiling to analyze host cell responses.
  • Conducted in vivo studies to assess parasite control and T cell responses.

Main Results:

  • Rhoptry protein injection alone induced an M2 macrophage phenotype dependent on STAT3 and STAT6.
  • Only infected cells showed reduced expression of antimicrobial and immune genes.
  • STAT3 or STAT6 deficiency improved parasite control in vivo.
  • ROP16 deficiency significantly reduced parasite numbers and enhanced T cell responses.

Conclusions:

  • ROP16 acts as a virulence factor, promoting M2 polarization via STAT3/STAT6.
  • ROP16 limits the magnitude of parasite-specific T cell responses.
  • Targeting ROP16 may be a strategy for controlling toxoplasmosis.